Mucormycosis in post-COVID patients: An Anaesthesia perspective

Abstract

COVID-19 pandemic has presented as a major health problem worldwide. There has been wide range of presentation of COVID-19 ranging from mild (flu-like symptoms) to severe life-threatening pneumonia with multi-organ involvement. Steroids have shown some ray of hope in its management. Although, systemic steroids have shown to have survival benefits but rampant use of glucocorticoids have resulted in secondary bacterial and fungal infections.